Researchers use blood testing to predict level of enzymes that facilitate disease progression

Researchers are developing a technique for predicting from a simple blood sample the amount of cathepsins -- protein-degrading enzymes known to accelerate certain diseases -- a specific person would produce. This patient-specific information may be helpful in developing personalized approaches to treat these tissue-destructive diseases.

Read the whole article on Science Daily

More from Science Daily